Abstract
Travelers’ diarrhea is common. Between 8% and 50% of travelers develop diarrhea; incidence depends on the country visited. The attack rate is highest for travelers from a developed country who visit a developing country. Children are at particular risk. Travelers’ diarrhea is usually acquired through ingestion of fecally contaminated food and water. Most cases are due to a bacterial pathogen, commonly,Escherichia coli, and occur within the first few days after arrival in a foreign country. More than 90% of episodes develop within the first 2 wk of initiation of travel. Dehydration is the most common complication. Water and electrolyte replenishment is important and can usually be accomplished with an oral rehydration solution. Judicious use of an antimotility agent and antimicrobial therapy reduces the duration and severity of diarrhea. Pretravel education on hygiene and on the safe selection of food items is important in minimizing episodes. Dukoral™ (Aventis Pharma Ltd., Auckland, New Zealand) vaccine should be considered for travelers who are 2 y of age or older and who will be visiting an area associated with risk of infection due to enterotoxigenicE coli orVibrio cholerae. Typhoid vaccine is recommended for travelers who will be visiting areas with poor sanitation and hygiene.
Similar content being viewed by others
References
Al-Abri SS, Beeching NJ, Nye FJ. Traveller’s diarrhoea.Lancet Infect Dis. 2005;5:349–360.
Lima AAM. Tropical diarrhoea: new developments in travellers’ diarrhoea.Curr Opin Infect Dis. 2001;14:547–552.
Guerrant RL, Bobak DA. Traveler’s diarrhea (turista). In: Mandell GL, Bennett JE, Dolin R, eds.Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. Philadelphia, Pa: Elsevier; 2005:1241–1243.
Yates J. Traveler’s diarrhea.Am Fam Physician. 2005;71:2095–2100.
McIntosh IB, Reed JM, Power KG. Travellers’ diarrhoea and the effect of pre-travel health advice in general practice.Br J Gen Pract. 1997;47:71–75.
Caeiro JP, Dupont HL. Management of travellers’ diarrhoea.Drugs. 1998;56:73–81.
John CC, Salata RA. Travelers’ diarrhea. In: Behrman RE, Kliegman RM, Jenson HB, eds.Nelson Textbook of Pediatrics. Philadelphia, Pa: WB Saunders; 2004:1194–1196.
Sack RB. The diarrhea of travelers. In: Goldman L, Ausiello D, eds.Cecil Textbook of Medicine. Philadelphia, Pa: WB Saunders; 2004:1864–1865.
Cartwright RY. Food and waterborne infections associated with package holidays.J Appl Microbiol. 2003;94:12S-24S.
Committee to Advise on Tropical Medicine and Travel (CATMAT). An Advisory Committee Statement (ACS). Statement on travellers’ diarrhea.Can Commun Dis Rep. 2001;27(ACS-3):1–12.
Brewster SJ, Taylor DN. Epidemiology of travelers’ diarrhea. In: Keystone JS, Kozarsky PE, Freedman DO, et al, eds.Travel Medicine. Philadelphia, Pa: Mosby; 2004:175–184.
Evans MR, Schickle D, Morgan MZ. Travel illness in British package holiday tourists: prospective cohort study.J Infect. 2001;43:140–147.
Kollaritsch H. Travellers’ diarrhea among Austrian tourists in warm climate countries. I. Epidemiology.Eur J Epidemiol. 1989;5:74–81.
Ericsson CD. Travellers’ diarrhoea.Int J Antimicrob Agents. 2003;21:116–124.
Steffen R. Epidemiologic studies of travelers’ diarrhea, severe gastrointestinal infections, and cholera.Rev Infect Dis. 1986;8(suppl 2):S122-S130.
de las Casas C, Adachi J, DuPont H. Travellers’ diarrhea.Aliment Pharmacol Ther. 1999;13: 1373–1378.
Steffen R, Castelli F, Nothdurft HD, et al. Vaccination against enterotoxigenicEscherichia coli, a cause of travelers’ diarrhea.J Travel Med. 2005;12;102–107.
Weinberg M, Maloney SA. Prevention of travelers’ diarrhea in children. In: Feigin RD, Cherry JD, Demmler GJ, et al, eds.Textbook of Pediatric Infectious Diseases. Philadelphia, Pa: WB Saunders; 2004:2858–2866.
Shetty A, Mendall M. Diagnosing gastroenteritis and travellers’ diarrhoea.Practitioner. 2001; 245:192–204.
Committee to Advise on Tropical Medicine and Travel (CATMAT). An Advisory Committee Statement (ACS). Persistent diarrhea in the returned traveller.Can Commun Dis Rep. 1998; 24(ACS-1):1–8.
Löscher T, Connor BA. Clinical presentation and treatment of travelers’ diarrhea. In: Keystone JS, Kozarsky PE, Freedman DO, et al, eds.Travel Medicine. Philadelphia, Pa: Mosby; 2004: 191–199.
Thomson MA, Booth IW. Treatment of traveller’s diarrhoea: economic aspects.Pharmacoecomonics. 1996;9:382–391.
Ellis C. Diarrhoea in the returned traveller.Practitioner. 1996;240:188–192.
Okhuysen PC. Current concepts in travelers’ diarrhea: epidemiology, antimicrobial resistance and treatment.Curr Opin Infect Dis. 2005;18:522–526.
Robson WL, Leung AK, Kaplan BS. Hemolytic-uremic syndrome.Curr Probl Pediatr. 1993;23:16–33.
Leung AK, Darling P, Auclair C. Oral rehydration therapy—a review.J R Soc Health. 1987;107:64–67.
Gore SM, Fontaine O, Pierce NF. Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials.BMJ. 1992;304:287–291.
Leung AK, Robson WL. Acute diarrhea in children: what to do and what not to do.Postgrad Med. 1989;86:161–174.
deBruyn G, Hahn S, Borwick A. Antibiotic treatment for travellers’ diarrhoea.Cochrane Database Syst Rev. 2000;(3):CD 002242.
Keenum AJ, Stockton MD. Rifaximin (Xifaxan) for travelers’ diarrhea.Am Fam Physician. 2005; 72:2525–2526.
Vila J, Vargas M, Ruiz J, et al. Susceptibility patterns of enteroaggregativeEscherichia coli associated with traveller’s diarrhoea: emergence of quinolone resistance.J Med Microbiol. 2001; 50:996–1000.
Hilton E, Kolakowski P, Singer C, et al. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers.J Travel Med. 1997;4:41–43.
Katelaris PH, Salam I, Farthing MJ. Lactobacilli to prevent traveler’s diarrhea?N Engl J Med. 1995;333:1360–1361.
Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of travellers’ diarrhoea by Lactobacillus GG.Ann Med. 1990;22:53–56.
Committee to Advise on Tropical Medicine and Travel (CATMAT) and National Advisory Committee on Immunization (NACI). An Advisory Committee Statement (ACS). Statement on new oral cholera and travellers’ diarrhea vaccination.Can Commun Dis Rep. 2005;31(ACS-7):1–11.
Black RE, Levine MM, Clements ML, et al. Protective efficacy in humans of killed whole-Vibrio oral cholera vaccine with and without the B subunit of cholera toxin.Infect Immun. 1987;55: 1116–1120.
Peltola H, Siitonen A, Kyrönseppä H, et al. Prevention of traveller’s diarrhoea by oral B-subunit/ whole-cell cholera vaccine.Lancet. 1991;338:1285–1289.
American Academy of Pediatrics. International travel. In: Pickering LK, ed.Red Book: 2003 Report of the Committee on Infectious Diseases. Elk Grove Village, Ill: American Academy of Pediatrics; 2003:93–98.
Steinberg EB, Bishop R, Haber P, et al. Typhoid fever in travelers: who should be targeted for prevention?Clin Infect Dis. 2004;39:186–191.
Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.N Engl J Med. 2006;354:11–22.
Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.N Engl J Med. 2006;354:23–33.
Leung AK, Kellner JD, Davies HD. Rotavirus gastroenteritis.Adv Ther. 2005;22:476–487.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leung, A.K.C., Robson, W.L.M. & Davies, H.D. Travelers’ diarrhea. Adv Therapy 23, 519–527 (2006). https://doi.org/10.1007/BF02850040
Issue Date:
DOI: https://doi.org/10.1007/BF02850040